Online Media
Groupon Stock: Are Investors Doubtful Ahead of Earnings Report?
Across 2018, Groupon stock was poised to bring the next major bull run in the small-cap market. The reason was two-fold: Analysts predicted that Groupon (NASDAQ:GRPN) could make the perfect acquisition target, and improving operational margins ... [Read]
Computer Hardware
Fitbit Stock: What Investors Should Know Ahead of Earnings Report
Fitbit (NYSE:FIT) is all set to report its fiscal first-quarter results on May 1, 2019, and thus investors will be eyeing Fitbit stock for signs of regaining its spark. Fitbit Projects Moderate Growth The company ... [Read]
Cannabis
CORRECTING and REPLACING Sproutly Announces Joint Venture with Moosehead Breweries to Launch Cannabis-Infused Beverages in Canada
NOT FOR DISSEMINATION IN THE US OR THROUGH US NEWSWIRE SERVICES Sproutly Canada Inc. (CSE:SPR) (OTCQB:SRUTF) (FRA: 38G) (“Sproutly” or the “Company”), and OCC Holdings Ltd., an affiliate of Moosehead Breweries Limited (“Moosehead”), are pleased to ... [Read]
Oil & Gas
ROAN Stock Up 36% After Multiple Parties Express Interest in Acquiring It
ROAN stock is skyrocketing Monday, April 29. Why? Well, it has to do with Roan Resources (NYSE:ROAN) announcing that multiple parties want to do a deal with it. Here’s what we know. ROAN Stock: Mergers ... [Read]
Communications
Penny Stocks in Satellite Communications: Is GSAT For You?
At $0.50 USD a pop, are penny stocks in satellite communications a potential play? Do you believe this technology is on the up? If so, then Globalstar (NYSE:GSAT) might suit your portfolio. Let’s check this ... [Read]
Biotechnology
AXSM Stock Climbs 550%: Key Drivers Investors Should Be Looking For
Little known biopharmaceutical AXSM stock has been on a tear, and the stock has jumped by a staggering 550% as big news regarding one of the Axsome Therapeutics Inc’s (NASDAQ:AXSM) drugs proved decisive for many ... [Read]
Cannabis
Chemistree Gains Access to Medical CBD Market Through Strategic Investment into The Physician’s Choice CBD
Chemistree Technology Inc. (CSE:CHM) (OTCQB:CHMJF) released some exciting news Monday that will expand its CBD portfolio and give the company exposure to the medical CBD market. Chemistree announced that it has entered into a funding ... [Read]
Press Release
Chemistree Acquires Ownership Stake in The Physician’s Choice CBD LLC
– Doctor created, CBD from Hemp Pain Management Company VANCOUVER, April 29, 2019 /PRNewswire/ – Chemistree Technology Inc. (CSE:CHM) and (CHM.wt) (US OTCQB:CHMJF) (the “Company” or “Chemistree”), is pleased to announce that the Company has ... [Read]
Autos
How Investors Can Get in on the Expanding Electric Vehicles Market
Electric vehicles are gaining popularity at a rapid pace, propelled by growing affordability, cutting-edge technology, and a global push to reduce carbon emissions. With more and more auto giants looking to enter the electric vehicle ... [Read]
Biotechnology
IPATF Stock Soars: Subsidiary Receives Exclusive License from Stanford
On Friday, April 26, ImmunoPrecise Antibodies’ subsidiary U-Protein Express disclosed that it’s obtained an exclusive license from Stanford University. The license allows U-Protein Express to manufacture and sell Wnt surrogate Fc. On the news, IPATF ... [Read]